Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 31, 2010Expert Opinion on Investigational Drugs

Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

View Full Paper
Ask AI
Bookmark
Share

Authors

TKThomas KungActelion (United States)JSJochen SpringerGerman Centre for Cardiovascular ResearchWDWolfram DoehnerHeart Failure & Transplant

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kung et al. (2010) studied this question.

synapsesocial.com/papers/6a90ebadc8472108f273c752https://doi.org/10.1517/13543781003724690
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pleiotropic Effects of Angiotensin‐Converting Enzyme Inhibitors and the Future of Cachexia Therapy2005 · 12 citations
  2. 2Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene2003 · 1,815 citations
  3. 3Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia2005 · 143 citations
  4. 4Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women2004 · 1,205 citations
  5. 5Induction of Cachexia in Mice by Systemically Administered Myostatin2002 · 918 citations